from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1691/-

LFCtreatmentdescriptionclass of inhibitor

-0.296

Amikacinug/mL Amikacintranslation

0.044

Cap5-10ug/mL Capreomycintranslation

0.330

Rox10-50 ug/mL Roxithromycintranslation

-0.132

SM2-5 ug/mL Streptomycintranslation

-0.899

Tet5-10 ug/mL Tetracyclinetranslation

-0.271

Rif0.2-5ug/mL Rifampicintranscription

0.311

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.376

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

1.227

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.163

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.728

Clofazimine10-13 ug/mL Clofaziminerespiration

0.318

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.283

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

1.107

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.393

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.163

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.285

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-1.071

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-1.407

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.401

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.156

KCN5-20 ug/mL Potassium cyaniderespiration

0.488

NaN30.2-2 mM Sodium aziderespiration

-0.356

Nigericin50 uM Nigericinrespiration

1.055

TRC10-150 ug/mL Triclosanrespiration

1.092

TRZ10-25 ug/mL Thioridazinerespiration

0.664

Valinomycin0.5-10 uM Valinomycinrespiration

-1.299

ZnSO42 mM ZnSO4respiration

-0.359

menadione6-10 ug/mL Menadionerespiration

-1.034

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.306

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.830

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.662

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.742

NRP_1Non-replicating persistence stage 1dosRassociated

0.243

Amp0.2mg/mL AmpicillincellWall

0.452

Cephalexin20-100 ug/mL CephalexincellWall

0.083

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.015

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.130

EMB10-20 ug/mL EthambutolcellWall

0.924

Eta12-40 ug/mL EthionamidecellWall

1.272

INH0.2-0.4 ug/mL IsoniazidcellWall

0.117

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.139

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.585

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.908

BZA0.12 mg/mL BenzamidearomaticAmides

0.354

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.312

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-1.361

H2O24 mM hydrogen peroxideDNAdamaging

-0.348

Levo10 ug/mL LevofloxacinDNAdamaging

0.397

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-1.143

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.102

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.135

UVUV-irradiationDNAdamaging

-0.648

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.554

Antimycin12.5-50 ug/mL Antimycin A?

-0.221

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.135

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.266

PA_2110-50 ug/mL Antitubercular compound PA-21?

-1.139

PA8240.2-2 ug/mL PA-824?

0.126

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.110

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.060

Verapamil50 uM Verapamil?

-0.033

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.716

methoxatin10-20 ug/mL Methoxatin?